$CVRX
CVRx, Inc.

2023 Q3 Form 10-Q Financial Statement

#000155837023013225 Filed on August 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $10.51M $9.500M
YoY Change 69.92% 88.83%
Cost Of Revenue $1.691M $1.517M
YoY Change 26.19% 26.31%
Gross Profit $8.820M $7.983M
YoY Change 82.01% 108.43%
Gross Profit Margin 83.91% 84.03%
Selling, General & Admin $15.65M $16.45M
YoY Change 23.45% 31.76%
% of Gross Profit 177.46% 206.13%
Research & Development $2.696M $3.280M
YoY Change 17.58% 39.28%
% of Gross Profit 30.57% 41.09%
Depreciation & Amortization $137.0K $127.0K
YoY Change 7.87% 33.68%
% of Gross Profit 1.55% 1.59%
Operating Expenses $18.35M $19.74M
YoY Change 22.55% 32.95%
Operating Profit -$9.528M -$11.75M
YoY Change -5.91% 6.7%
Interest Expense $499.0K -$481.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net $1.056M $616.0K
YoY Change 221.95% -1911.76%
Pretax Income -$8.971M -$11.62M
YoY Change -8.44% 5.15%
Income Tax $40.00K $34.00K
% Of Pretax Income
Net Earnings -$9.011M -$11.65M
YoY Change -8.33% 5.24%
Net Earnings / Revenue -85.73% -122.64%
Basic Earnings Per Share -$0.43 -$0.56
Diluted Earnings Per Share -$0.43 -$0.56
COMMON SHARES
Basic Shares Outstanding 20.76M 20.71M
Diluted Shares Outstanding 20.80M 20.71M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $83.00M $90.82M
YoY Change -24.54% -25.16%
Cash & Equivalents $82.99M $90.82M
Short-Term Investments
Other Short-Term Assets $3.300M $3.543M
YoY Change 7.63% 206.75%
Inventory $10.89M $10.93M
Prepaid Expenses
Receivables $6.372M $6.726M
Other Receivables $0.00 $0.00
Total Short-Term Assets $103.6M $112.0M
YoY Change -16.73% -15.1%
LONG-TERM ASSETS
Property, Plant & Equipment $1.723M $2.934M
YoY Change -1.37% 82.24%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $26.00K $27.00K
YoY Change 0.0% 3.85%
Total Long-Term Assets $2.807M $2.961M
YoY Change 29.71% 40.93%
TOTAL ASSETS
Total Short-Term Assets $103.6M $112.0M
Total Long-Term Assets $2.807M $2.961M
Total Assets $106.4M $115.0M
YoY Change -15.94% -14.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.133M $2.933M
YoY Change -11.21% 382.4%
Accrued Expenses $6.274M $5.992M
YoY Change 2.52% 13.04%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.407M $8.925M
YoY Change 0.15% 51.04%
LONG-TERM LIABILITIES
Long-Term Debt $14.29M $14.25M
YoY Change
Other Long-Term Liabilities $960.0K $1.831M
YoY Change 26.15% 150.14%
Total Long-Term Liabilities $15.25M $16.08M
YoY Change 1904.47% 2097.27%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.407M $8.925M
Total Long-Term Liabilities $15.25M $16.08M
Total Liabilities $23.58M $25.01M
YoY Change 182.97% 262.92%
SHAREHOLDERS EQUITY
Retained Earnings -$468.2M -$459.2M
YoY Change 10.0% 10.44%
Common Stock $551.3M $549.4M
YoY Change 1.31% 1.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $82.83M $89.96M
YoY Change
Total Liabilities & Shareholders Equity $106.4M $115.0M
YoY Change -15.94% -14.22%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$9.011M -$11.65M
YoY Change -8.33% 5.24%
Depreciation, Depletion And Amortization $137.0K $127.0K
YoY Change 7.87% 33.68%
Cash From Operating Activities -$8.120M -$12.81M
YoY Change -26.82% 26.86%
INVESTING ACTIVITIES
Capital Expenditures $40.00K $143.0K
YoY Change -115.15% -391.84%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$40.00K -$143.0K
YoY Change -84.85% 191.84%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 360.0K 473.0K
YoY Change 5042.86% 47.35%
NET CHANGE
Cash From Operating Activities -8.120M -12.81M
Cash From Investing Activities -40.00K -143.0K
Cash From Financing Activities 360.0K 473.0K
Net Change In Cash -7.800M -12.48M
YoY Change -31.3% 27.02%
FREE CASH FLOW
Cash From Operating Activities -$8.120M -$12.81M
Capital Expenditures $40.00K $143.0K
Free Cash Flow -$8.160M -$12.95M
YoY Change -24.67% 28.9%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20711850
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20505228
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20702589
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20479427
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.11
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.03
dei Entity Central Index Key
EntityCentralIndexKey
0001235912
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2023Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40545
dei Entity Registrant Name
EntityRegistrantName
CVRx, Inc
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-1983744
dei Entity Address Address Line1
EntityAddressAddressLine1
9201 West Broadway Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 650
dei Entity Address City Or Town
EntityAddressCityOrTown
Minneapolis
dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55445
dei City Area Code
CityAreaCode
763
dei Local Phone Number
LocalPhoneNumber
416-2840
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20663736
dei Security12b Title
Security12bTitle
Common stock,
dei Trading Symbol
TradingSymbol
CVRX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20756651
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
90815000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
106194000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
602000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
679000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6726000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5504000
CY2023Q2 us-gaap Inventory Net
InventoryNet
10928000
CY2022Q4 us-gaap Inventory Net
InventoryNet
6957000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3543000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4223000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
112012000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
122878000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1821000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1698000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1113000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
334000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
27000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
27000
CY2023Q2 us-gaap Assets
Assets
114973000
CY2022Q4 us-gaap Assets
Assets
124937000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2933000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1719000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5992000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6369000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
8925000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8088000
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
14253000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6747000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
946000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
117000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
885000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
805000
CY2023Q2 us-gaap Liabilities
Liabilities
25009000
CY2022Q4 us-gaap Liabilities
Liabilities
15757000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20750910
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
208000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
207000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
549150000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
545362000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-459207000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-436182000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-187000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-207000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
89964000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
109180000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
114973000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
124937000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9500000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5031000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17479000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9107000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
1517000
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
1201000
us-gaap Cost Of Revenue
CostOfRevenue
2845000
us-gaap Cost Of Revenue
CostOfRevenue
2150000
CY2023Q2 us-gaap Gross Profit
GrossProfit
7983000
CY2022Q2 us-gaap Gross Profit
GrossProfit
3830000
us-gaap Gross Profit
GrossProfit
14634000
us-gaap Gross Profit
GrossProfit
6957000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3280000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2355000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6696000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4613000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16455000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12489000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
31852000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
23266000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
19735000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
14844000
us-gaap Operating Expenses
OperatingExpenses
38548000
us-gaap Operating Expenses
OperatingExpenses
27879000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-11752000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-11014000
us-gaap Operating Income Loss
OperatingIncomeLoss
-23914000
us-gaap Operating Income Loss
OperatingIncomeLoss
-20922000
CY2023Q2 us-gaap Interest Expense
InterestExpense
481000
CY2022Q2 us-gaap Interest Expense
InterestExpense
0
us-gaap Interest Expense
InterestExpense
721000
us-gaap Interest Expense
InterestExpense
0
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
616000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-34000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1678000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-91000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11617000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11048000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22957000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21013000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
68000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-11651000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-11071000
us-gaap Net Income Loss
NetIncomeLoss
-23025000
us-gaap Net Income Loss
NetIncomeLoss
-21062000
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
17000
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-7000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
20000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-13000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11634000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11078000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23005000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21075000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.11
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.03
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20711850
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20711850
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20505228
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20505228
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20702589
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20702589
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20479427
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20479427
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
99642000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
28000
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
452000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1476000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-11651000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
17000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
89964000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
136803000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
26000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
295000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1100000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-11071000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
127146000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
109180000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
156000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
452000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3181000
us-gaap Net Income Loss
NetIncomeLoss
-23025000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
20000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
89964000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
145959000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
74000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
295000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1893000
us-gaap Net Income Loss
NetIncomeLoss
-21062000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-13000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
127146000
us-gaap Profit Loss
ProfitLoss
-23025000
us-gaap Profit Loss
ProfitLoss
-21062000
us-gaap Share Based Compensation
ShareBasedCompensation
3181000
us-gaap Share Based Compensation
ShareBasedCompensation
1893000
us-gaap Depreciation
Depreciation
256000
us-gaap Depreciation
Depreciation
157000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-4000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
73000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1222000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1041000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3971000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1954000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-689000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1421000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1214000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
98000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-256000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-252000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23057000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20740000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
383000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
342000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-383000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-342000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
156000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
74000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
452000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
295000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
7500000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
67000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8041000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
369000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-13000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-15379000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-20726000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106194000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
142072000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
90815000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
121346000
us-gaap Interest Paid Net
InterestPaidNet
563000
us-gaap Interest Paid Net
InterestPaidNet
0
us-gaap Income Taxes Paid
IncomeTaxesPaid
4000
us-gaap Income Taxes Paid
IncomeTaxesPaid
1000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Use of estimates</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results could differ from those estimates.</p>
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
4420000
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2390000
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
2333000
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1033000
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4175000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3534000
CY2023Q2 us-gaap Inventory Net
InventoryNet
10928000
CY2022Q4 us-gaap Inventory Net
InventoryNet
6957000
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4343000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3978000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2522000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2280000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1821000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1698000
CY2023Q2 us-gaap Depreciation
Depreciation
127000
CY2022Q2 us-gaap Depreciation
Depreciation
95000
us-gaap Depreciation
Depreciation
256000
us-gaap Depreciation
Depreciation
157000
CY2023Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2033000
CY2022Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2303000
CY2023Q2 cvrx Accrued Paid Time Off
AccruedPaidTimeOff
1234000
CY2022Q4 cvrx Accrued Paid Time Off
AccruedPaidTimeOff
960000
CY2023Q2 cvrx Clinical Trial And Other Professional Fees
ClinicalTrialAndOtherProfessionalFees
1086000
CY2022Q4 cvrx Clinical Trial And Other Professional Fees
ClinicalTrialAndOtherProfessionalFees
1733000
CY2023Q2 cvrx Accrued Liabilities Customer Rebate Current
AccruedLiabilitiesCustomerRebateCurrent
282000
CY2022Q4 cvrx Accrued Liabilities Customer Rebate Current
AccruedLiabilitiesCustomerRebateCurrent
256000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
185000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
222000
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
83000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
120000
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1089000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
775000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5992000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6369000
CY2023Q2 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.050
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y8M12D
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
10000000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
5000000
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
15000000
CY2023Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
747000
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
14253000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1113000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
334000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
185000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
222000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
946000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
117000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1131000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
339000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
119000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
223000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
255000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
262000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
270000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
161000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1290000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
159000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1131000
CY2023Q2 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P5Y2M12D
us-gaap Operating Lease Payments
OperatingLeasePayments
200000
us-gaap Operating Lease Payments
OperatingLeasePayments
600000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3756835
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.28
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
36616000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
993401
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
13.73
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
187897
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
9.27
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
52753
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.95
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4509586
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.50
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
28416000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2165087
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.81
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
19577000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y8M12D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y4M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1476000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1100000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3181000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1893000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1476000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1100000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3181000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1893000
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
14800000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
68000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-11651000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-11071000
us-gaap Net Income Loss
NetIncomeLoss
-23025000
us-gaap Net Income Loss
NetIncomeLoss
-21062000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20711850
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20505228
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20702589
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20479427
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.03
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5225717
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4168211
CY2023Q2 us-gaap Contractual Obligation
ContractualObligation
0
CY2022Q4 us-gaap Contractual Obligation
ContractualObligation
0
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9500000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5031000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17479000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9107000

Files In Submission

Name View Source Status
0001558370-23-013225-index-headers.html Edgar Link pending
0001558370-23-013225-index.html Edgar Link pending
0001558370-23-013225.txt Edgar Link pending
0001558370-23-013225-xbrl.zip Edgar Link pending
cvrx-20230630.xsd Edgar Link pending
cvrx-20230630x10q.htm Edgar Link pending
cvrx-20230630xex31d1.htm Edgar Link pending
cvrx-20230630xex31d2.htm Edgar Link pending
cvrx-20230630xex32d1.htm Edgar Link pending
cvrx-20230630xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
cvrx-20230630_cal.xml Edgar Link unprocessable
cvrx-20230630_def.xml Edgar Link unprocessable
cvrx-20230630_lab.xml Edgar Link unprocessable
cvrx-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cvrx-20230630x10q_htm.xml Edgar Link completed
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending